publication venue for
- Author Correction: Interplay of diverse adjuvants and nanoparticle presentation of native-like HIV-1 envelope trimers. 2021
- Characterization and immunogenicity of nanoparticle vaccines based on Clade 2 and Clade 3 sarbecovirus S2 proteins. 2025
- Polyvalent mRNA vaccine targeting outer surface protein C affords multi-strain protection against Lyme disease. 2025
- Durable T cell immunity to COVID-19 vaccines in MS patients on B cell depletion therapy.. 10. 2025
- Impact of inactivated vaccine on transmission and evolution of H9N2 avian influenza virus in chickens.. 10. 2025
- RBD-depleted SARS-CoV-2 spike generates protective immunity in cynomolgus macaques.. 10. 2025
- Triple tandem trimer immunogens for HIV-1 and influenza nucleic acid-based vaccines.. 9. 2024
- Multivalent cytomegalovirus glycoprotein B nucleoside modified mRNA vaccines did not demonstrate a greater antibody breadth.. 9. 2024
- Accelerated prime-and-trap vaccine regimen in mice using repRNA-based CSP malaria vaccine.. 9. 2024
- Conjugation of HIV-1 envelope to hepatitis B surface antigen alters vaccine responses in rhesus macaques.. 8. 2023
- Vaccination with a replication-defective cytomegalovirus vaccine elicits a glycoprotein B-specific monoclonal antibody repertoire distinct from natural infection.. 8. 2023
- Assessing immunogenicity barriers of the HIV-1 envelope trimer.. 8. 2023
- Profound structural conservation of chemically cross-linked HIV-1 envelope glycoprotein experimental vaccine antigens.. 8. 2023
- Fine-mapping the immunodominant antibody epitopes on consensus sequence-based HIV-1 envelope trimer vaccine candidates.. 7. 2022
- CD4 T cell epitope abundance in ferritin core potentiates responses to hemagglutinin nanoparticle vaccines.. 7. 2022
- Heat-inactivated modified vaccinia virus Ankara boosts Th1 cellular and humoral immunity as a vaccine adjuvant.. 7. 2022
- Leveraging antigenic seniority for maternal vaccination to prevent mother-to-child transmission of HIV-1.. 7. 2022
- An adjuvanted zoster vaccine elicits potent cellular immune responses in mice without QS21.. 7. 2022
- Persistent immunogenicity of integrase defective lentiviral vectors delivering membrane-tethered native-like HIV-1 envelope trimers.. 7. 2022
- High thermostability improves neutralizing antibody responses induced by native-like HIV-1 envelope trimers.. 7. 2022
- A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern.. 6. 2021
- Interplay of diverse adjuvants and nanoparticle presentation of native-like HIV-1 envelope trimers.. 6. 2021
- Access to and equitable distribution of COVID-19 vaccine in low-income countries.. 6. 2021
- Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles.. 6. 2021
- Heterologous viral protein interactions within licensed seasonal influenza virus vaccines.. 5. 2020
- An autophagy-inducing and TLR-2 activating BCG vaccine induces a robust protection against tuberculosis in mice.. 4. 2019
- A new era in cytomegalovirus vaccinology: considerations for rational design of next-generation vaccines to prevent congenital cytomegalovirus infection. 2018